Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration.

Cell reports·2022
Same author

Altered stability of nuclear lamin-B marks the onset of aging in male Drosophila.

PloS one·2022
Same author

Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants.

Human mutation·2017
Same author

Optogenetic inhibition of behavior with anion channelrhodopsins.

Nature methods·2017
Same author

Candidate ionotropic taste receptors in the Drosophila larva.

Proceedings of the National Academy of Sciences of the United States of America·2015
Same author

The Drosophila IR20a clade of ionotropic receptors are candidate taste and pheromone receptors.

Neuron·2014

Related Experiment Video

Updated: Jun 28, 2025

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

7.5K

Genetic modifiers of synucleinopathies-lessons from experimental models.

Rachel Min Qi Lee1, Tong-Wey Koh1,2

  • 1Temasek Life Sciences Laboratory, 1 Research Link, Singapore, 117604, Singapore.

Oxford Open Neuroscience
|April 10, 2024
PubMed
Summary

Genetic modifiers of alpha-synuclein (α-synuclein) in experimental models offer insights into synucleinopathies like Parkinson's disease. Studying these conserved modifiers aids in developing new disease-modifying treatments.

Keywords:
Drug targetsGenetic modifiersLewy bodiesParkinson’s diseaseSNCAα-synuclein

More Related Videos

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

8.2K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.2K

Related Experiment Videos

Last Updated: Jun 28, 2025

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

7.5K
Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

8.2K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.2K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Alpha-synuclein (α-synuclein) aggregation is central to synucleinopathies, including Parkinson's disease and dementia with Lewy bodies.
  • Understanding synucleinopathy mechanisms is challenging due to limited human biopsy access.
  • Experimental models are crucial for studying disease progression and identifying therapeutic targets.

Purpose of the Study:

  • To review the role of genetic modifiers of α-synuclein in understanding synucleinopathies.
  • To explore how conserved genetic modifiers inform disease mechanisms.
  • To highlight the contribution of modifier studies to developing disease-modifying interventions.

Main Methods:

  • Review of literature on genetic modifiers of α-synuclein across various experimental models (yeast, flies, organoids).
  • Analysis of conserved genetic elements influencing α-synuclein function and aggregation.
  • Synthesis of findings linking genetic modifiers to disease pathogenesis and therapeutic strategies.

Main Results:

  • Numerous evolutionarily conserved genetic modifiers of α-synuclein have been identified using diverse experimental models.
  • These modifiers provide insights into the complex biological pathways involved in synucleinopathies.
  • Modifier studies have revealed potential targets for therapeutic interventions.

Conclusions:

  • Genetic modifiers are powerful tools for dissecting α-synuclein biology and synucleinopathy mechanisms.
  • Targeting conserved modifiers holds promise for developing effective treatments for Parkinson's disease and related disorders.
  • Continued research into genetic modifiers is essential for advancing therapeutic strategies.